Our Vision - Brighter Futures with the Power of Light.
Investor Relations Presentation I May/June 2026 © Copyright Jenoptik. All rights reserved.
Agenda
Company overview
Divisional set-up
Results Q1/2026 and outlook
Appendix
Jenoptik at a glance - a leading globally operating photonics group
1991
>80
~4,500
~2.05bn1
Fiscal year 2025
~1.05 bn
18.4
Year of foundation Represented in countries Employees worldwide
Our Mission
The Leading Light In the Application of Photonics
Focus on four growth areas
− Semiconductor technology
− Medical technology
− Metrology
− Smart Mobility
Market capitalization in euros
Revenue in euros
EBITDA margin in %
1 as of 8.5.2026
We enable the digital age
Addressing multiple mega-trends with our strong photonics expertise
We enable the digital age
We ensure superb quality in demanding production processes
We drive life science
and healthcare development
We make roads and cities safer
Clear focus on attractive markets
OEM
businesses
Solutions businesses
Semiconductor & Advanced
Manufacturing
Metrology & Production Solutions
42%
OEM businesses generate
~2/3 of revenue
20%
Biophotonics
Smart Mobility Solutions
12%
23%
3%
Semi Bio Metrology Mobility Others
Based on FY 2025 data
Strong value proposition:
Leading photonics expertise combined with strong customer relationships
Customer access / relationship
Technology
Joint R&D
programmes
Shared R&D roadmaps
Designed-in solutions
Application excellence
Industrial manufacturing know how
Manufacturing capacity
Supplier
Joint R&D projects
Evolution
Joint roadmaps
Joint ecosystem (Partner)
Portfolio has been aligned to future markets of photonics; focus on organic growth
Priorities Initiatives
Organic growth
Operational excellence
Innovation
Utilization of photonic
growth platforms
− Increased customer focus
− Investment in new application areas and regions
− Reorganization
Allocation of production units
Stronger standardization
− Continuous investment in development (e.g. micro-optics, optics, automation)
Streamlined organizational structure implemented to enhance customer focus and efficiency
Jenoptik has become more simple
− Matrix structure largely removed in 2024
− Full allocation of plants to individual
Strategic Business Units
Stronger customer focus, more efficiency clearer responsibilities
A
dvanced Manufactur
Semiconductor &
ing
Biophotonics
OEM businesses
Metrology & Production Solutions
Smart Mobility Solutions
Solution businesses
Robust track record of profitable growth
2014 - 2025
Revenue CAGR >5%
EBITDA margin increased >5 percentage points
Main driver to margin expansion
− Product mix effects
− Operating leverage
1200
1150
1100
1050
1000
950
900
850
800
750
700
650
600
550
500
450
400
350
300
18.8%1
19.7%
19.9%
21,0%
19,0%
17,0%
15,0%
13,0%
11,0%
18.4%
~590
million euros
12.9%
13.3%
14.2%
14.3%
15.3%
15.7%
15.1%1
16.7%1
2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Revenues Discontinued Operation EBITDA margin1) EBITDA margin of continuing operations; for 2021 excluding one-off items
Substantial investments to support organic growth
New Semi Fab in Dresden
Significant investments into production capacities
− Doubling production with new micro-optics cleanroom fab
(LEED certified) in Dresden; production started in early 2025
− New biophotonics production site in Berlin inaugurated in June 2023; capacity significantly expanded
− Continuous investment into production equipment
Relocation & expansion in Berlin
Capex and capex ratio
160
120
80
40
0
10.8 10.4 10.3 12
5.1
6.5
6.2
6.6
7,4
8
4
0
2018 2019 2020 2021 2022 2023 2024 2025
Capex in million euros (lhs) Capex rel. to revenue in %Capex significantly declined in 2025
Robust key financial figures; net debt reflects recent acquisitions
Jenoptik Group | Q1/2026 | FY 2025 | 700 600 |
Equity ratio in % | 60.4 | 60.2 | 500 |
Net debt in million euros | 313.0 | 317.4 | 400 300 |
Net debt / EBITDA | 1.6x | 1.6x | 200 100 |
0 |
Key financial ratios
Net debt and net debt to EBITDA1
Acquisition BG Medical/
SwissOptic (end 2021)
1.6x
Q1/21 Q2/21 Q3/21 Q4/21 Q1/22 Q2/22 Q3/22 Q4/22 Q1/23 Q2/23 Q3/23 Q4/23 Q1/24 Q2/24 Q3/24 Q4/24 Q1/25 Q2/25 Q3/25 Q4/25 Q1/26
4,0
3,5
3,0
2,5
2,0
1,5
1,0
0,5
0,0
Financing
Net debt in million euros Net debt / EBITDA (rhs)
(lhs) -69 -27,2
1 FY 2022 EBITDA (LTM) of continuing operations
− Substantial financing capacities available based on undrawn credit facilities (~300 million euros at the end Q1/2026)
Capital allocation priorities in current strategy period focus on organic growth
Capital allocation 2018 - 2024
~10%
~35%
~1.2bn euros of capital allocated 2018 - 2025
~55%
M&A CAPEX DividendsNew capital allocation priorities
3
2
1
Investment into organic growth (Capex, R&D)
Return to shareholders
Bolt-on acquisitions
New sustainability targets 2030
Jenoptik's
sustainability ratings
03/2025 Bronze Status 2025
Top Performer (65/100)
09/2025 AA Rating - Top 17 percent ranked in global Electronics Components Sector
Target 2025 | Target 2030 |
>90% | 100% |
>55% | 70% |
33% | 33% |
|
Better than global benchmark | Better than global benchmark |
>4% | >4.5% |
50% | New target being developed |
ESG-Area |
Environment |
Social |
Governance/ others |
KPI | 2025 | |
Share of green | 96.8% | |
CO2 reduction | 59.0% | |
Diversity rate | 31.0% | |
electricity
Engagement score
73%
Apprentice Rate 4.5%
CSR rate 64.0%
Reach net zero (Scope 1+2) by 2035 at the latest
Divisional set-up
Leaner organizational structure to increase customer focus and efficiency and more clearly assign responsibilities
Semiconductor & Advanced Manufacturing
− Optical and micro-optical modules & subsystems for the semiconductor equipment industry
− Information and communication technologies and other
applications
Biophotonics
− Optical components for life science & medical technology industry
− Various industrial applications (incl.
security and defense)
Metrology & Production Solutions
− Systems and service for inspection, metrology and production solutions for optical, electronics and
automotive industries
Smart Mobility Solutions
− Camera systems and services for traffic surveillance, civil security and roads
user charging
MORE customer focus / MORE direct business responsibility / MORE efficiency
Jenoptik is strongly rooted in main applications IC lithography and IC inspection
Markets
Semiconductor & Advanced Manufacturing
Main characteristics
− Supplier to global manufacturers of wafer fab equipment for optical lithography and inspection
− Performance-critical, designed-in optical and micro-optical modules and subsystems
− Few key accounts / deep & long-term customer relationships
− Global R+D and manufacturing footprint
Market position
− Strategic supplier for high-end optical solutions, leveraging emerging technologies
− Unique technology portfolio; from nano-structured to classical optics
− Deep experience in semiconductor industry & markets
Financial profile
Revenue 2025: | EBITDA 2025: | Manufacturing footprint: |
EUR 434.4m | EUR 114.2m | Jena (GER), Dresden (GER), |
(−11.7% yoy) | Margin: 25.7% | Heerbrugg (CH), Jupiter (US), Wuhan (CN) |
Semiconductor market expectations remain robust;
Multiple drivers support mid-term equipment market growth
Wafer Fab Equipment Market1 (billion USD)
Main chip demand drivers:
Digitalization
(AI & cloud infrastructure, 5G connectivity, edge computing)
Climate change & resource scarcity
180
150
120
90
CAGR 2025-28: ~9%(Electrification & smart mobility, energy transition)
Social and economic shifts
(Working remotely, automation, technological sovereignty)
Main capacity demand drivers:
60
30
0
2020 2021 2022 2023 2024 2025 2026 2027 2028
WFE Market
Chip production volume growth Chip technology advancement
Technological sovereignty, energy transition
1 SEMI.org
Jenoptik Investor Relations Presentation 18
Chip manufacturing: photonics plays a critical role along the process
Front-end
Back-end | |
Wafer level packaging | Packaging |
Inspection/Metrology
Inspection/Metrology
e.g. co-packaged optics
e.g. advanced / 3D-
packaging
Etching
CMP
Implant
Lithography
Deposition
Diffusion
Jenoptik core technology portfolio
Main photonics applications
Use of photonics
Jenoptik leverages its strong position in the global semi supply chain; revenues more than doubled since 2020 - CAGR (organic) >10%
Key business features:
Close customer relationships with leading OEM's
Broad technology portfolio & deep application know-how
Main demand drivers:Chip fabrication capacity expansion
New technologies both front and back end
Growing installed base
Strong track record in supplying function-critical components & modules
Joint development and designed-in products
Significant capacity expansion largely completed
Source: ASML
20
Target to continuously increase share of wallet
New state-of-the-art fab in Dresden opened on time in Q1 2025
− Largest single investment in recent history (just under 100m euros)
− Expanding production & research and development
capacities for innovative micro-optics
− Extremely demanding manufacturing environment (clean rooms meet the highest requirements for vibration-free operation and temperature stability)
Well positioned to support mid-term demand for high-performance chips, e.g. for AI
Developing new applications in the area of Medtech & Life Sciences
Markets
Main characteristics
− Supplier to global Medtech & Life Science OEM manufacturers
− Performance-critical, designed-in modules and sub-systems
− Key account approach / strong relationship to market leading customers
− Serves selective industrial applications (e.g., defense & security, automation)
Market position
− Strength in combining optics, illumination, detection and assembly know-how
− Strong position in certain applications, e.g., dentistry, ophthalmology, DNA-sequencing
− Develop growth opportunities in new fields, e.g., surgery
Financial
profile
Revenue 2025:
EUR 245.4m (+10.4% yoy)
EBITDA 2025: EUR 52.2m
Margin: 21.1%
Manufacturing footprint: Jena (GER), Berlin (GER),
Triptis (GER), Heerbrugg (CH) Jupiter (US)
Biophotonics: main Medtech and Life Sciences applications and drivers
Our products portfolio enables diagnostics and therapy, e.g.
− imaging solutions for dentistry and (robotic) surgery
− disk lasers for ophthalmology
− readheads for DNA sequencing and fluorescence microscopy
− illumination and cameras for optical microscopy
− detectors for electron microscopy
− diode laser stacks for esthetics
− Growing and aging population, better access to healthcare in developing countries
− New therapeutic approaches (e.g., personalized medicine / minimal invasive procedure), and digitization
− Overall average end-market growth in medtech and life science market expected at mid-single digit rate1
− Changes in geopolitical situation
1) Fortune Business Insights
Key market drivers
Biophotonics: optical defense portfolio & position
Well established supplier of high-end optical defense products
Our product portfolio supports defense and industrial applications by leveraging technological synergies, e.g.
Laser rangefinders
Thermal imaging (IR) cameras
Light Emitting Diodes (LEDs)
Infrared and polymer optics
Applications mainly relate to surveillance and targeting
Land
Air
Naval
Well established global customer base
Addressing highly specialized application with a broad portfolio for efficient quality control and production solutions
Main
characteristics
Metrology & Production Solutions
Markets
− Supplier of high-end testing and production solutions incl. service
− Main end-markets include automotive and electronics, as well as industries producing optics
− Broad customer-base (OEM, Tier 1/integrators, component manufacturers)
Market position
− Global sales and service infrastructure in place
− Leading position in certain niches, e.g., smart phone camera & AR/VR testing, airbag perforation, shaft measurement
− Develop growth opportunities in new/emerging fields, e.g., AR/VR, adjacent automotive applications
− Realize service opportunity
Financial profile
Revenue 2025:
EUR 206.7m (−7.0% yoy)
EBITDA 2025:
EUR 16.1m
Margin: 7.8%
Manufacturing footprint:
Villingen-Schwenningen (GER), Wedel (GER),
Jena (GER), Bayeux (FR), Shanghai (CN)
Deploying strong technology basis to realize growth opportunities in new/emerging fields
ELECTRONICS manufacturing
OPTICS manufacturing
AUTOMOTIVE manufacturing
Quality Inspection
adjacent applications
Visionline
Opticline
ProCam
OptiSurf
OptiCentric
ImageMaster
Mechanical
parts testing
Shaft measurement
JENvelt
Advanced production technologies
AR/VR and Smartphone testing
Lens assembly & testing
Measurement of center thicknesses and air gaps
ADAS
Votan A
alignm. & testing
Laser material processing
Airbag perforation
Addressing highly specialized application with a broad portfolio of quality control and production solutions
Markets
Smart Mobility Solutions
Main characteristics
− Provider of solutions for traffic law enforcement, civil security and road user charging
− Offers equipment and software, including integration, installation and maintenance through to full-service operation (~40% recurring revenue)
− Global public sector customer basis (local and central governments, police etc.)
Market position
− Very strong market position in certain markets including UK, Germany and Australia
− Strong basis for future growth of direct business in North America
− Addressing growth opportunities: distracted driving, automatic number plate recognition
Financial profile
Revenue 2025:
EUR 129.7m (+8.5% yoy)
EBITDA 2025:
EUR 17.7m
Margin: 13.6%
Manufacturing footprint:
Monheim (GER), Camberley (UK)
Smart Mobility Solutions Division: main demand drivers and applications
Traffic Law Enforcement Civil Security
− New applications such as distracted driving
− Growing demand for integrated services
− Political initiatives such as Vision Zero in additional countries
− Overall average market growth expected at ~8-10%1
Road User Charging1) MarketsandMarkets report
Equipment & full service provider
Redlight monitoring
Speed & average speed control (fixed & mobile)
Moving vehicle offenses
Distracted driving
Automatic number plate recognition for e.g. border control, predictive analytics
Road user charging & emission control
Results
first quarter 2026
OEM businesses drive significant increase in order intake
Semiconductor & Advanced Manufacturing
Biophotonics
Metrology &
Production Solutions
Smart Mobility Solutions
Business development:
− Substantially higher demand in OEM business, in particular in the semiconductor equipment industry
− Revenue slightly down on prior year, as expected
− EBITDA margin significantly improved
− Free cash flow influenced by demand-driven increase in working capital
Continuous focus on main growth opportunities:
− Set to leverage strong market positions (technology and customer relations)
− AI-driven semi demand, optical communication for data centers, defense, expansion of SMS business in US, and AR/VR
Outlook 2026 confirmed
Highest quarterly order intake in years supported by single major order, amongst other things
Order intake in MEUR
204.6
74.4%
356.9
In million euros | Q1/2026 | Q1/2025 Change in % | |
Semiconductor & Advanced Manufacturing | 180.2 | 68.6 162.7 | |
Biophotonics | 73.9 | 44.7 65.5 | |
Metrology & Production Solutions | 53.3 | 50.5 5.4 | |
Smart Mobility Solutions | 37.7 | 38.3 −1.6 | |
Other | 11.8 | 2.5 364.3 | |
400
300
200
100
0
Q1/2025 Q1/2026
− Semiconductor & Advanced Manufacturing: strong demand (including major order), particularly in the lithography and inspection businesses (prior year: negative one-off effect resulting from a one-time product adjustment)
− Biophotonics: substantially higher demand in medtech & life science and in defense business
− Metrology & Production Solutions and Smart Mobility Solutions: order intake in line with expectations
− Book-to-bill ratio 1.48 (prior year: 0.84)
− Order backlog amounted to 719.2 million euros (31.12.2025: 590.8 million euros)
Q1/2026: revenue still slightly below prior year
Revenue in MEUR
243.6
− 1.0%
241.2
In million euros | Q1/2026 | Q1/2025 Change in % | |
Semiconductor & Advanced Manufacturing | 108.2 | 100.9 7.2 63.8 -10.9 40.6 -3.7 28.7 10.9 9.6 -44.8 | |
Biophotonics | 56.8 | ||
Metrology & Production Solutions | 39.1 | ||
Smart Mobility Solutions | 31.8 | ||
Other | 5.3 | ||
300
200
100
0
Q1/2025 Q1/2026
− Semiconductor & Advanced Manufacturing: stronger revenue in particular in inspection
− Biophotonics: higher revenue in the defense and life science areas; very strong prior-year basis due to dental business
− Metrology & Production Solutions: automotive market remains challenging
− Smart Mobility Solutions: strong development in all regions
− 77.2% of revenue generated abroad (prior year: 72.7%)
EBITDA margin increased to 18.4% compared to modest prior-year level of 14.9%
EBITDA in MEUR
36.2
22.5%
44.4
EBITDA in million euros EBITDA in % | |||||
Q1/2026 | Q1/2025 | Q1/2026 | Q1/2025 20.5 24.4 -8.3 6.6 - | ||
Semiconductor & Advanced Manufacturing | 33.7 | 21.4 15.6 −3.4 1.9 0.7 | 30.6 | ||
Biophotonics | 12.5 | 21.9 | |||
Metrology & Production Solutions | -0.2 | -0.4 | |||
Smart Mobility Solutions | 3.7 | 11.6 | |||
Other | -5.4 | - | |||
50
40
30
20
10
0
Q1/2025 Q1/2026
− Cost-cutting measures implemented in 2025
− Semiconductor & Advanced Manufacturing: better utilization and change in product mix (prior year: costs for move in Dresden included)
− Biophotonics: strong profitability retained despite lower revenues
− Smart Mobility Solutions and Metrology & Production Solutions: positive development
Earnings figures clearly above modest prior-year level
In million euros |
Revenue |
Gross margin |
Functional costs |
Other operating result |
EBITDA |
EBIT |
Financial result |
Earnings before tax |
Earnings after tax |
Earnings per share (euros) |
Q1/2026 |
241.2 |
35.4% |
59.6 |
0 |
44.4 |
25.9 |
−2.4 |
23.5 |
16.8 |
0.29 |
Q1/2025 | Change in % | |
243.6 | −1.0 | |
30.9% | ||
58.4 | 2.1 | |
−0.1 | n.a. | |
36.2 | 22.5 | |
16.9 | 53.4 | |
−4.1 | 41.6 | |
12.8 | 83.9 | |
9.2 | 82.5 | |
0.16 | 81.3 |
− Gross margin influenced in particular by higher contribution of Semiconductor & Advanced Manufacturing
− Functional cost ratio amounted to 24.7% (prior year: 24.0%)
- R+D expense ratio: 6.7% (prior year: 6.6%)
- Selling expense ratio: 10.5% (prior year: 10.4%)
-
Administrative expense ratio: 7.6% (prior year: 7.0%)
− EBIT margin increased to 10.7% (prior year 6.9%)
− Financial result impacted by lower interest expenses and
currency losses
− Tax rate at 28.8% (prior year: 28.3%)
Cash-effective tax rate of 22.0% (prior year: 25.3%)
Free cash flow impacted by increase in working capital; financial position remains very strong
In million euros |
Cash flows from operating activities before income taxes |
Cash flows from operative investing activities |
Free cash flow (before interest and income tax payments) |
Net debt |
Equity ratio |
Q1/2026 |
28.7 |
−12.8 |
15.9 |
313.0 |
60.4% |
*31.12.2025
Q1/2025 Change in %
54.9 −47.7
−26.0 50.8
28.9 −44.8 317.4* −1.4 60.2%* n.a.− Cash flows from operating activities impacted by
increase (prior year: reduction) in working capital
− Cash flows from operative investing activities influenced in particular by payments for property, plant and equipment
− Cash conversion rate at 35.9% (prior year: 79.8%)
− Leverage: 1.6x (net debt to EBITDA / 31.12.2025: 1.6x)
− Capital expenditure amounted to 10.1 million euros (prior year 14.4 million euros)
− Working capital ratio at 31.8% (31.12.2025: 29.1% /
31.3.2025: 29.0%)
Revenue and margin guidance for 2026 confirmed
Targets 2026
Semiconductor & Advanced Manufacturing
Biophotonics
Metrology &
Production Solutions
Smart Mobility Solutions
− Revenue increase in single-digit percentage range (2025: 1,046.0 million euros)
− EBITDA margin between 19.0 and 21.0 percent (2025: 18.4%)
− Investments slightly below prior year (2025: 77.4 million euros)
The guidance is subject to the assumption that political and economic conditions do not deteriorate, including in particular economic trends, the war in Ukraine, the conflict in the Middle East, European and international regulations, and macroeconomic developments.
Potential portfolio changes are not considered in this forecast.
Appendix
Innovation remains our main growth engine through our leading competencies in…
− Harnessing light
− Helping our customers to solve highly complex
photonic problems
− Design and industrialization of complex optics and photonics components
− Decoding photonic signals in data imaging solutions
Approx. 670 R+D colleagues are dedicated to drive
innovation and to engineer novel solutions.
Investment into future applications such as AR/VR will continue.
R+D output in million euros1
11,0%
9,0%
7,0%
5,0%
3,0%
1,0%
-1,0%
9.2%
8.9%
8.9%
8.5%
8.0%
8.5%
9.5%
2019
2020
2021
2022
2023
2024
2025
©NASA/JPL-Caltech
120
90
60
30
0
R&D expenses R&D customer projects R&D output rel. to revenue1) R+D output incl. R+D expenses, developments on behalf of customers as well as capitalized R+D
Megatrends will drive growing demand for photonics solutions of the future
Societal needs
Jenoptik's contribution
Digitization
Health
Mobility
Sustainability
Global photonics market CAGR of ~6%1 until 2030
Growing demand for chips for various existing as well as new applications; increasing usage of augmented and virtual reality
Aging population >> increasing demand for therapies, diagnostics and bioimaging
Increasing demand for intelligent safety solutions
Solutions for e.g. climate protection, sustainable
mobility, efficient use of resources
Jenoptik supplies high-performance optics, micro-optics for semiconductor equipment as well as innovative test & measurement systems
Jenoptik supplies optical systems e.g. for genome sequencing and digital image processing, microscope cameras and laser systems
Jenoptik supplies innovative products for more safety on roads and in cities
Jenoptik enables its customers to produce more efficiently for greater resource conservation and climate protection
1) Verified Market Research
A long tradition of innovation in optoelectronics
19 20 21 22 23
1846 1946
1989-91
1992-98
1998-2006
2007-16
since 2017
Founded | State | German | New | Flexibility | Consolidation | Sustainable |
in Jena by | property | Reunification | Businesses | profitable growth |
Carl Zeiß
"Workshop for precision mechanics and optics"
The Zeiss plant in Jena, converted into state property
Acquisition of companies to open up new sales channels
IPO 1998
Strategy "More Light" in 2018
Starting new strategy
"More Value" in 2021
Um den Rest dieser Noodl zu lesen, rufen Sie bitte die Originalversion auf, und zwar hier.
Attachments
- Original document
- Permalink
Disclaimer
Jenoptik AG published this content on May 13, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 13, 2026 at 15:15 UTC.



















